retatrutide safety profile (not yet approved in US but people using anyway) promises even potentially greater weight loss amongst the GLP1 drugs. https://www.nejm.org/doi/full/10.1056/NEJMoa2301972 Retatrutide: Comprehensive Safety and Clinical

Alm disso, observa-se uma melhora na funo endotelial e uma reduo nos marcadores inflamatrios sistmicos, o que pode retardar a progresso da aterosclerose

GLP-1 therapy is often intended for ongoing use

Patients using GLP-1 RAs for weight loss (AOM) were more likely to discontinue due to perceived completion of therapy or no longer needing the medication suggesting that some view these drugs as short-term solutions rather than components of ongoing chronic disease management

GLP-1 stands for glucagon like peptide1, a naturally occurring hormone that helps regulate appetite, digestion, and blood sugar

doi: 10.1016/j.ijpharm.2023.123549

Usage, dosage & frequency Ozempic and Mounjaro are both weekly subcutaneous injections via pre-filled pens